Phynd Technologies is a privately held, venture-funded company focused on solving the health care provider data management problem. Founded in 2012, Phynd enables health care organizations to improve financial results and clinical outcomes, while reducing the risk by securely gathering, managing, and sharing mission-critical provider data.Phynd Technologies is a privately held, venture-funded company focused on solving the health care provider data management problem. Founded in 2012, Phynd enables health care organizations to improve financial results and clinical outcomes, while reducing the risk by securely gathering, managing, and sharing mission-critical provider data.
Dr. Gust Bardy founded BardyDX in 2013 to overcome common challenges in ambulatory cardiac monitoring. The company has developed the Carnation Ambulatory Monitor (CAM), a lightweight ECG patch monitor with a lightweight, easy to wear device with a focus on measuring the P-wave. The additional clarity in ECG readings allow physicians to gather more information about the heart rhythm to use in clinical diagnoses.
Gauss Surgical is a leading company in maternal health. Their innovative Triton platform enables physician to utilize AI-powered technology for real time monitoring of surgical blood loss. The applications for obstetric blood loss monitoring in both the operating room and labor room has helped the industry shift from Estimated Blood Loss into Quantified Blood Loss.
Emergo is an innovative bio-technology startup focusing on developing treatments that target the release of inflammatory molecules – tuning down inflammation at its source.
Arrivo BioVentures is a privately-held biopharmaceutical company focused on accelerating and developing biologics and small molecules through clinical development that have the potential to improve patient lives.
Inspired by the success of HCV-TARGET, a case study of the TARGET model in hepatitis C, TARGET PharmaSolutions was formed in February 2015. Target PharmaSolutions is a clinical data company that provides pharmaceutical partners a more efficient way to generate data that can be used to better understand the natural history of diseases, including treatment outcomes in the real world setting.
“Working with Rex Health Ventures has been a tremendous asset to TARGET PharmaSolutions. As our lead investor, they have provided critical strategic guidance and financial support that has enabled us to quickly scale.” – TARGET PharmaSolutions CEO Meg Powell
Veran Medical Technologies
Veran is a privately-held medical device company headquartered in St. Louis, MO. The company’s main focus is assisting physicians in the early diagnosis and treatment of lung cancer. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States.
Phononic is revolutionizing cooling and heating with solid-state thermal management solutions. Named to CNBC’s 2016 Disruptor 50 list for its innovation within the cooling and heating industry, as well as CNBC’s Disruptor 50 list for both 2016 and 2017, Phononic provides solid-state semiconductor technology that can be applied to everything from refrigeration to fiber optics, removing the barriers of traditional approaches and ushering in a new era of cooling and heating. UNC REX served as the first testing site for Phononic’s medical grade refrigerator, which will now be installed throughout the new NC Heart and Vascular hospital.
“Rex Health Ventures recognizes that entrepreneurs need value beyond capital…the voice of the customer and market dynamics that RHV provides – often misjudged or unknown to an entrepreneur – are a blueprint to market adoption, growth and increased revenues.” – Phononic CEO Tony Atti
Midnight Pharma LLC
Midnight Pharma LLC is an early stage biopharmaceutical development company that is developing a novel product for the treatment of insomnia. Midnight is privately-held, and was founded in 2015 by the management team from Aerial BioPharma, Addrenex Pharmaceuticals and Neuronex, all founded in the RTP region of North Carolina.
Kit CheckTM is the leader in automated hospital pharmacy kit processing and medication tracking software. Since 2012, Kit Check has focused on replacing time-consuming and error-prone manual processes in hospital medication handling with faster and safer automation technologies driven by a scalable cloud software platform. Headquartered in Washington, D.C., Kit Check serves more than 200 hospital pharmacies throughout the United States.
“Rex Health Ventures has been a supportive and helpful strategic investor. They have the combination of a smart team and strong connections in a world class health system. This allows RHV to offer their portfolio companies capabilities that many strategic investors tout but which very few actually deliver.” – Kevin McDonald, Kit Check CEO
Baebies delivers innovative products and services to advance newborn screening and pediatric testing worldwide. The company offers SEEKER®, the only newborn screening platform authorized by the U.S. FDA for lysosomal storage diseases and is developing FINDERTM, a rapid near-patient pediatric testing solution. By bringing new technologies and new tests to the healthcare community, Baebies is providing hope to parents and the chance at a better life to newborns.
Founded in 2002, Awarepoint leads the innovation of real-time location systems (RTLS) and the practical applications of location as a service. The company’s integrated solutions and patented technologies, based on Bluetooth Low Energy (BLE) and Wi-Fi, simplify the implementation of proven RTLS applications across the Internet of Things (IoT) continuum, enabling clients to rapidly achieve unprecedented benefits and rapid return on investment.
Aerial BioPharma is a development stage biopharmaceutical company focused on developing biologics and small molecules for conditions in the central nervous system. Aerial is a privately held company, founded in January 2011 by the management team from Addrenex Pharmaceuticals and Neuronex, two successful startup companies founded in the RTP region of North Carolina. In 2014, Jazz Pharmaceuticals acquired Aerial’s primary compound in clinical development for the treatment of excessive daytime sleepiness in patients with narcolepsy.